<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Dilon-Technologies on Bioecon</title><link>https://en.bioecon.ru/companies/dilon-technologies/</link><description>Recent content in Dilon-Technologies on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Mon, 20 Jul 2026 14:22:31 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/companies/dilon-technologies/index.xml" rel="self" type="application/rss+xml"/><item><title>Intraoperative molecular diagnostics</title><link>https://en.bioecon.ru/technology/intraoperative-molecular-diagnostics/</link><pubDate>Mon, 20 Jul 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/intraoperative-molecular-diagnostics/</guid><description>Real-time, in-the-operating-room molecular and optical tissue identification — fluorescence imaging agents, OCT, stimulated Raman histology and mass-spectrometry tissue analysis — that lets surgeons assess tumor margins during the procedure instead of waiting on frozen-section pathology: On Target Laboratories and Dilon Technologies (fluorescence/RF-spectroscopy margin agents), Perimeter Medical Imaging AI (AI-enabled OCT), Invenio Imaging (stimulated Raman histology) in the US, and photonamic and Imperial College London (iKnife/REIMS) in Europe.</description></item></channel></rss>